Case Reports in Cardiology
Volume 2018 (2018), Article ID 4739830, 5 pages
https://doi.org/10.1155/2018/4739830

Case Report

Cardiac Tamponade from Purulent Pericarditis due to Cutibacterium acnes

Ardalon Farhat-Sabet,¹ Robert Hull,² and Dustin Thomas²

¹Department of Internal Medicine, Brooke Army Medical Center, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA
²Department of Cardiology, Brooke Army Medical Center, 3551 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA

Correspondence should be addressed to Ardalon Farhat-Sabet; ardalon.m.farhatsabet.mil@mail.mil

Received 5 July 2018; Revised 5 November 2018; Accepted 7 November 2018; Published 18 November 2018

Academic Editor: Gianluca Di Bella

Copyright © 2018 Ardalon Farhat-Sabet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Purulent pericarditis is a potentially fatal disease with high mortality rates if untreated. Cutibacterium acnes (formerly Propionibacterium acnes) is an anaerobic bacteria that is ubiquitous in skin flora and is commonly thought of as a culture contaminant; however, it does have pathogenic potential. We present a case of purulent pericarditis secondary to C. acnes leading to cardiac tamponade. Initial stabilization and diagnosis were made via pericardiocentesis; afterward the patient underwent a pericardial window. Due to a severe penicillin allergy, he was successfully treated with a 14-day course of vancomycin. To our knowledge, this represents only the third published case of purulent pericarditis with cardiac tamponade caused by C. acnes and the first case treated with a 14-day course of vancomycin.

1. Introduction

Purulent pericarditis is a rare subset of bacterial pericarditis that is characterized by gross or microscopic purulence in the pericardium and most commonly develops from direct contiguous spread of an intrathoracic infection (such as pneumonia or mediastinitis) or intracardiac source and less commonly via hematogenous spread. Prior to World War II, purulent pericarditis was a fairly common disease with an incidence as high as 1 in 254 persons. In today’s age of modern antimicrobials, however, the incidence has decreased to 1 in 18,000 persons. Likewise, the spectrum of causal organisms has also changed, transitioning from an overwhelming majority of gram-positive organisms to the inclusion of gram-negative and anaerobic organisms. Despite decreasing incidence and improved antimicrobials, purulent pericarditis remains an important cause of morbidity and mortality as it is rapidly progressive and highly fatal if left untreated [1, 2]. Several known complications of purulent pericarditis are reported to include cardiac tamponade, constrictive pericarditis, left ventricular pseudoaneurysm, and aortic mycotic aneurysm formation, among others [1–3]. The severity of these complications makes a high index of suspicion imperative to allow prompt diagnosis and treatment.

2. Case Presentation

A 71-year-old male presented to cardiology clinic with a 3-week history of worsening dyspnea, night sweats, and subjective fevers. Of note, he underwent an ischemic evaluation one week prior that was significant for newly identified left pleural effusion, moderate pericardial effusion, and mild pericardial thickening on chest CT (Figure 1).

Figure 1: Diffuse pericardial thickening and adjacent fat stranding.

Initial physical exam was significant for a heart rate of 107 beats per minute and relative hypotension at 98/61 mmHg. Additionally, heart sounds were distant but jugular venous distention was absent. Later appreciated to have potential relevance, he was noted to have facial acne. Electrocardiogram revealed sinus tachycardia. Transthoracic echocardiogram (TTE) was performed which revealed that the effusion increased by greater than one centimeter since the most recent echocardiogram nine days prior and was now large and circumferential with early right ventricular diastolic collapse concerning for tamponade physiology (Figures 2 and 3). However, it also noted a nonplethoric inferior vena cava (IVC) and a lack of exaggerated respiratory inflow variability.

Figure 2: RA diastolic collapse prior to pericardiocentesis.

Figure 3: RV diastolic collapse prior to pericardiocentesis.

Urgent pericardiocentesis was performed with removal of 370 mL of nonclotting serosanguinous fluid with immediate hemodynamic and symptomatic improvement. Gram stain of pericardial fluid demonstrated microscopic purulence with mixed inflammatory cells. Empiric broad-spectrum antibiotic therapy with vancomycin was initiated. Both 72-hour aerobic cultures and anaerobic cultures held for six days were negative. Full laboratory data from before and after the pericardiocentesis can be found in the table below (Table 1).

Table 1: Laboratory results from before and after pericardiocentesis.

Before pericardiocentesis
After pericardiocentesis
Before pericardial window
After completion of intravenous antibiotic therapy

WBC (×10³)
13.1 (92.5% neutrophils)
9.4 (59.2% neutrophils)
10.7 (76% neutrophils)
5.3 (59% neutrophils)

Hemoglobin (g/dL)
12.3
10.4
9.5
8.0

Hematocrit (%)
37.1
31.8
29.1
25.3

Platelets (fL)
166
356
294
220

C-reactive protein (mg/dL)
7.20
Not available
Not available
2.5

Erythrocyte sedimentation rate (mm/hr)
104
Not available
Not available
Not available

Repeat bedside transthoracic echocardiogram on day three demonstrated resolution of the previously noted anterior effusion. With these imaging findings and with minimal pericardial drain output noted, the drain was removed. On day five, the patient experienced recurrent tachycardia to 121 beats per minute, relative hypotension at 97/64 mmHg, and tachypnea to 28 breaths per minute, prompting evaluation for pulsus paradoxus which was found to be 18 mmHg. Repeat TTE showed a large effusion and recurrent evidence of tamponade physiology (Figure 4). Following a heart team discussion, subxiphoid pericardial window and left-sided chest tube for pleural effusion were performed with removal of 800 mL and 200 mL of serosanguinous output, respectively. Anterior adhesions of the pericardium as well as loculated posterior pericardial effusion requiring blunt dissection were noted intraoperatively.

Figure 4: Recurrent circumferential pericardial effusion and large pleural effusion demonstrated prior to pericardial window.

Intraoperative anaerobic cultures of the pleural and pericardial fluid grew C. acnes after six and seven days, respectively, and anaerobic blood cultures from admission grew the same organism two weeks later. These results can be found in the table below (Table 2). Histopathology of operative pericardial samples showed fibrinous pericarditis with granulation tissue formation. Given the patient’s history of anaphylaxis to penicillin, he was initiated on a 14-day course of parenteral vancomycin. The patient was discharged from the hospital in stable condition and his symptoms remained controlled at follow-up. Also noted on follow-up was resolution of the pericardial effusion as seen on TTE (Figures 5 and 6).

Table 2: Pleural and pericardial fluid analysis.

Pericardial fluid (pericardiocentesis)
Pericardial fluid (intraoperative)
Pleural fluid (intraoperative)

WBCs
Moderate
Moderate
Few present

RBCs
Too numerous to count
Too numerous to count
Too numerous to count

Cell count
4133 nucleated cells (73% segmented neutrophils)
467 nucleated cells (56% segmented neutrophils)
489 nucleated cells (26% segmented neutrophils)

Appearance
Bloody, purulent
Turbid
Turbid

pH
Not available
7.860
7.99

Triglycerides
Not available
127
153

Amylase (U/L)
Not available
18
20

Glucose
99
116
125

LDH (IU/L)
1545
389
1513

Organisms on staining
None seen
None seen
None seen

Fungal stain
Negative
Negative
Negative

Acid-fast stain
Negative
Negative
Negative

Culture
No growth (but discarded after 72 hours)
Cutibacterium acnes
Cutibacterium acnes

Figure 5: Resolution to trace pericardial effusion 8 weeks after completion of therapy.

Figure 6: TTE performed on hospital follow-up showing no significant pericardial effusion.

3. Discussion

Although its incidence is decreasing, purulent pericarditis remains an important clinical diagnosis to make given the high attributable morbidity and mortality rates. Classically, purulent pericarditis presents with fever, dyspnea, and tachycardia, with a median time from symptom onset to presentation of seven days. Clinicians must have a high index of suspicion as it infrequently presents with the classic features of acute pericarditis such as pericardial chest pain, electrical alternans, and a pericardial friction rub, all of which were absent in this case. Electrocardiogram findings are variable and often normal, lacking the classic diffuse ST segment elevation and PR interval depression commonly seen in idiopathic or viral pericarditis [1, 3].

It is prudent to understand the complicated interplay that can occur with the coexistence of hemodynamically significant pericardial disease and intravascularly volume-contracted states, such as that which occurs with sepsis physiology. Elevated pericardial pressure leads to compromised right ventricular filling greater than left ventricular filling resulting in impairment in stroke volume (SV). Cardiac output can be maintained in the setting of low SV with tachycardia until filling is impaired below a critical level or various compensatory mechanisms are overwhelmed as seen in classic tamponade. Thus, low preload states should be corrected with volume expansion. It is important to realize that tamponade can even occur with normal central venous pressures, so-called low-pressure tamponade [4]. As our report emphasizes, utilization of echocardiography can detect early tamponade changes that precede severe hypotension allowing for urgent, not emergent, pericardiocentesis in a more controlled setting.

Suspicion of purulent pericarditis should prompt urgent pericardiocentesis, a procedure which is both diagnostic and therapeutic. Aspirated fluid should be sent for cytology and bacterial, fungal, and tuberculous cultures. Additionally, blood cultures should be drawn to evaluate for bacteremia given the association with hematogenous spread [3]. Cultures should be kept for a minimum of seven days, as some organisms such as Cutibacterium acnes are unlikely to grow during the typical five-day incubation period [5, 6].

Identification and aggressive treatment of the infectious source must be initiated as soon as the diagnosis is made. Pneumonia and empyema are the most common sources, but other potential sources include mediastinitis, periodontal infection, subphrenic abscess, and sepsis [2]. Risk factors for the development of this disease include immunosuppression, chest wall trauma, and increased alcohol intake [2, 7].

Early detection and diagnosis are paramount in order to initiate appropriate antimicrobial therapy and drainage. Prompt treatment can prevent complications such as constrictive pericarditis and cardiac tamponade [3]. Treatment options for pericardial fluid drainage include percutaneous pericardiocentesis and surgical pericardiotomy. Percutaneous pericardiocentesis provides rapid drainage; however, approximately 40% of patients go on to require surgical pericardiotomy after initial drainage [3]. Surgical pericardiotomy has higher success rates and lower rates of associated constrictive pericarditis [1]. Adjunctive interventions, such as pericardiectomy or intrapericardial fibrinolysis, may be required in patients with dense adhesions, loculated and frankly purulent effusions, recurrent tamponade, persistent infection, and evidence of constrictive pericarditis [8–11].

Cutibacterium are gram-positive, catalase-positive, anaerobic bacilli. In general, Cutibacterium species have relatively low virulence and are slow-growing [12]. This pathogen is typically susceptible to penicillins, clindamycin, macrolides, quinolones, cephalosporins, and carbapenems. Resistance to aminoglycosides and metronidazole has been reported [13]. Given our patient’s history of anaphylaxis with penicillin, the decision was made to avoid penicillin desensitization and parenteral vancomycin therapy was selected in consultation with infectious disease specialists. Other reported antibiotic combinations for treatment of purulent pericarditis due to C. acnes include intravenous penicillin G for four weeks followed by twelve weeks of oral amoxicillin/clavulanic acid and intravenous penicillin G for six weeks followed by oral doxycycline for six weeks [5, 6]. There is no widely agreed-upon treatment duration, and duration should be guided by the specific source.

C. acnes is a rare cause of purulent pericarditis, although the incidence may be underestimated. Given its role as a normal component of skin flora, the growth of C. acnes is often dismissed and attributed to culture contamination. Additionally, the longer incubation time required to grow C. acnes may result in under detection given that most hospital systems discard blood cultures after a five-day incubation period [5, 6]. In the setting of pathologic infection, C. acnes has immune-stimulatory effects that promote inflammatory cell infiltration and fibrosis. Thus, when identified as the causative pathogen in pericardial infections, it commonly leads to pericardial inflammation, pericardial effusions, and constrictive physiology [14].

4. Conclusion

We reported a rare case of purulent pericarditis caused by Cutibacterium acnes, complicated by recurrent cardiac tamponade requiring surgical pericardiotomy which was successfully treated with a 14-day course of parental vancomycin due to a penicillin allergy. This case highlights the importance of a high clinical suspicion for the diagnosis given the lack of classic exam and electrocardiogram findings of pericarditis. Additionally, our case highlights the need to communicate directly with the microbiology lab to ensure adequate incubation times to detect less common pathogens.

Consent

Informed consent was obtained for publication of this case history and associated images in line with COPE recommendations and ICMJE guidelines.

Disclosure

The view(s) expressed herein are those of the authors and do not reflect the official policy or position of Brooke Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army or the Department of Defense, or the U.S. Government.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this paper.

Authors’ Contributions

All listed authors were involved in compilation of data and writing of this piece.

References

J. Sagristà-Sauleda, J. A. Barrabés, G. Permanyer-Miralda, and J. Soler-Soler, “Purulent pericarditis: review of a 20-year experience in a general hospital,” Journal of the American College of Cardiology, vol. 22, no. 6, pp. 1661–1665, 1993.

P. G. Klacsmann, B. H. Bulkley, and G. M. Hutchins, “The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients,” The American Journal of Medicine, vol. 63, no. 5, pp. 666–673, 1977.

S. V. Parikh, N. Memon, M. Echols, J. Shah, D. K. McGuire, and E. C. Keeley, “Purulent pericarditis: report of 2 cases and review of the literature,” Medicine, vol. 88, no. 1, pp. 52–65, 2009.

J. Sagristà-Sauleda, J. Angel, A. Sambola, J. Alguersuari, G. Permanyer-Miralda, and J. Soler-Soler, “Low-pressure cardiac tamponade: clinical and hemodynamic profile,” Circulation, vol. 114, no. 9, pp. 945–952, 2006.

D. Cruz, H. Ahmed, Y. Gandapur, and M. R. Abraham, “Propionibacterium acnes: a treatable cause of constrictive pericarditis,” Case Reports in Medicine, vol. 2015, Article ID 193272, 3 pages, 2015.

T. B. Jensen, M. A. E. Kheyr, and R. Mohey, “Constrictive pericarditis caused by Cutibacterium (Propionibacterium) acnes: a case report and review of literature,” IDCases, vol. 10, pp. 79–82, 2017.

R. H. Rubin and R. C. Moellering Jr, “Clinical, microbiologic and therapeutic aspects of purulent pericarditis,” The American Journal of Medicine, vol. 59, no. 1, pp. 68–78, 1975.

L. J. Goodman, “Purulent pericarditis,” Current Treatment Options in Cardiovascular Medicine, vol. 2, no. 4, pp. 343–350, 2000.

B. Maisch, P. M. Seferović, A. D. Ristić et al., “Guidelines on the diagnosis and management of pericardial diseases executive summary: the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology,” European Heart Journal, vol. 25, no. 7, pp. 587–610, 2004.

P. Augustin, M. Desmard, P. Mordant et al., “Clinical review: intrapericardial fibrinolysis in management of purulent pericarditis,” Critical Care, vol. 15, no. 2, p. 220, 2011.

Y. Adler, P. Charron, M. Imazio et al., “2015 ESC guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS),” European Heart Journal, vol. 36, no. 42, pp. 2921–2964, 2015.

M. Song, S. H. Seo, H. C. Ko et al., “Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea,” The Journal of Dermatology, vol. 38, no. 7, pp. 667–673, 2011.

E. A. Eady, M. Gloor, and J. J. Leyden, “Propionibacterium acnes resistance: a worldwide problem,” Dermatology, vol. 206, no. 1, pp. 54–56, 2003.

J. Y. Choi, M. S. Piao, J. B. Lee, J. S. Oh, I. G. Kim, and S. C. Lee, “Propionibacterium acnes stimulates pro-matrix metalloproteinase-2 expression through tumor necrosis factor-alpha in human dermal fibroblasts,” The Journal of Investigative Dermatology, vol. 128, no. 4, pp. 846–854, 2008.